4Fineout-Overhoh E, Melnyk BM, Stillwell SB, et al. Evidence -based practice step by step: Critical appraisal of the evi- dence: part Ⅰ [ J ].Am Nurs, 2010,110 (7) : 47- 52.
5Peng YL, Hu HY, Luo JC, et al. Alendronate, a bisphosphonate, in- creased upper and lower gastrointestinal bleeding: Risk factor analy- sis from a nationwide population-based study. Osteoporos Int, 2014, 25(5):1617-1623.
6Khamaysi I, Gralnek IM. Acute upper gastrointestinal bleeding (UGIB) - initial evaluation and management. Best Pract Res Clin Gastroenterol, 2013,27(5):633-638.
7Akira N, Keiko S,Yukinori M, et al. Analysis of dosimetrie param- eters Aassoeiated with aeute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer pa- tients treated with gemeitabine based concurrent ehemoradio thera-py [ J ]. Int J Radiat Oncol Biol Phys,2012,84 ( 2 ) : 369-375.
8Francis KL, Jessica YL, Bing YS, et al. Effects of helicobacter py- lori infection on long-term risk of peptic ulcer bleeding in low-dose aspirin users[ J]. Gastroenterology ,2013,144 (3) :528-535.
10Jorge F, Carlos CA, Rosa N, et al. Nonvarieeal upper gastrointesti- nal bleeding in portugal: a multicentric retrospective study in twelve Portuguese hospitals [ J ]. Gastroenterelogia Hepatologia, 2012,35(6) :377-385.
